Please login to the form below

Not currently logged in
Email:
Password:

New president at Bayer Healthcare

Dieter Weinand replaces departing Andreas Fibig
Bayer dieter Weinand

Bayer Healthcare has looked to Otsuka Pharmaceuticals to replace its departing president Andreas Fibig.

Dieter Weinand, who is currently president global commercialisation and portfolio management at Otsuka's US subsidiary, will step into his new role at Bayer Healthcare on August 1.

The announcement comes just one week after Weinand's predecessor Fibig announced his intention to leave Bayer Healthcare to join International Flavors & Fragrances as CEO.

Bayer Healthcare's parent group Bayer also announced this week that group CEO Marijn Dekkers will step down from his role at the end of 2016.

In addition to his time at Otsuka, Weinand boasts an impressive CV, serving across multiple regions and therapy areas for Pfizer and Bristole-Myers Squibb.

This includes roles as Pfizer's president for Asia-Pacific and as president for BMS' operations in Latin America and Canada.

6th June 2014

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...